Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chymase: the other ACE?

Literature DB >> 19923404

Chymase: the other ACE?

John N Lorenz.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2009 PMID： 19923404 PMCID： PMC2806114 DOI： 10.1152/ajprenal.00641.2009

Source DB: PubMed Journal: Am J Physiol Renal Physiol ISSN： 1522-1466

× No keyword cloud information.

6 in total

1. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

Authors: H Urata; A Kinoshita; K S Misono; F M Bumpus; A Husain
Journal: J Biol Chem Date: 1990-12-25 Impact factor: 5.157

2. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.

Authors: V Richard; S Hurel-Merle; E Scalbert; G Ferry; F Lallemand; J P Bessou; C Thuillez
Journal: Circulation Date: 2001-08-14 Impact factor: 29.690

3. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190

4. Major role for ACE-independent intrarenal ANG II formation in type II diabetes.

Authors: Sungmi Park; Benjamin J Bivona; Hiroyuki Kobori; Dale M Seth; Mark C Chappell; Eric Lazartigues; Lisa M Harrison-Bernard
Journal: Am J Physiol Renal Physiol Date: 2009-10-21

5. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.

Authors: Xiao R Huang; Wei Y Chen; Luan D Truong; Hui Y Lan
Journal: J Am Soc Nephrol Date: 2003-07 Impact factor: 10.121

Review 6. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.

Authors: Sheila A Doggrell; Janet C Wanstall
Journal: Cardiovasc Res Date: 2004-03-01 Impact factor: 10.787

6 in total

17 in total

1. Unraveling the glomerular RAS: one peptidase at a time.

Authors: Lisa M Harrison-Bernard; Mark C Chappell
Journal: Am J Physiol Renal Physiol Date: 2012-05-09

2. The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.

Authors: Ghezal Froogh; Sharath Kandhi; Roopa Duvvi; Yicong Le; Zan Weng; Norah Alruwaili; Jonathan O Ashe; Dong Sun; An Huang
Journal: Am J Physiol Heart Circ Physiol Date: 2020-03-13 Impact factor: 4.733

Review 9. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.

Authors: Claudio Borghi; Francesco Rossi
Journal: High Blood Press Cardiovasc Prev Date: 2015-09-24

Review 10. Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.

Authors: Hiroyuki Kobori; Masumi Kamiyama; Lisa M Harrison-Bernard; L Gabriel Navar
Journal: J Investig Med Date: 2013-02 Impact factor: 2.895

Chymase: the other ACE?

1. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

2. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.

3. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

4. Major role for ACE-independent intrarenal ANG II formation in type II diabetes.

5. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.

Review 6. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.

1. Unraveling the glomerular RAS: one peptidase at a time.

2. The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.

Review 3. The renin-angiotensin system and prevention of age-related functional decline: where are we now?

4. Chymase-dependent production of angiotensin II: an old enzyme in old hearts.

5. ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.

6. Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1-12) substrate.

Review 7. An evolving story of angiotensin-II-forming pathways in rodents and humans.

8. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.

Review 9. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.

Review 10. Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.